Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ViCentra

Explore full profile

Discreet, automated insulin patch pump system.

Utrecht, NetherlandsFounded 2013Health Tech & Medtech
Valuation $250–500M Last recorded · 2026
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ViCentra and the history behind them.

About ViCentra

Kaleido, operating under the website hellokaleido.com, is a healthcare startup that provides innovative solutions for individuals living with diabetes. The company's primary product is a compact, wearable insulin pump that offers flexibility and convenience to its users. The pump is designed to hold 200 units of rapid-acting insulin, with a battery life of three days, and can be worn underwater for up to an hour.

Kaleido's target market is individuals with diabetes who require insulin therapy. The company operates in the healthcare sector, specifically within the diabetes management market. The business model is centered around providing a product that offers a more convenient and flexible alternative to traditional insulin pumps.

Kaleido makes money by selling its insulin pumps to patients. The pumps are prescribed by healthcare professionals who believe insulin pump therapy is a suitable treatment option for their patients. The company's unique selling proposition is its micro pulse technology, which ensures consistent insulin delivery, and its easy-to-apply infusion sets, which are designed to make the process of using the pump as straightforward as possible.

In summary, Kaleido is a healthcare startup that offers an innovative, user-friendly solution for individuals requiring insulin therapy. Its product is designed to make living with diabetes more manageable, providing users with the freedom and flexibility to live their lives without the constraints of traditional insulin pumps.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Utrecht, Netherlands
Employees
202
Open positions
24
Dealroom signal
92.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Diabetes, Remote Monitoring, Tech for Patients, Horizon Europe, Digital Care, remote health monitoring, DT and LS, science-based
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Jan 2026 $12M $400M Innovation Industries · ROM Utrecht Region - Regional Development Agency · VENTURING TECH ↗
SERIES DOther financing Sep 2025 $80M $321M Health Innovations · Partners in Equity (PiE) · EQT Life Sciences · Invest-NL ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

ViCentra website traffic

Latest recorded traffic for ViCentra is 7.9K monthly website visits, down 28.2% over the last three months. ViCentra's team grew 17.4% over the past year.

Latest monthly visits7.9K 3-month web change-28.2% 1-year team growth+17.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Inkef
  • Health Innovations
  • EQT Life Sciences

Series B and later7 investors entered at this stage

  • Kreos Capital
  • Invest-NL
  • Partners in Equity (PiE)
  • Lsp
  • Innovation Industries
  • ROM Utrecht Region - Regional Development Agency
  • VENTURING TECH
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇳🇱 Netherlands86.1%
🇩🇪 Germany10.4%
🇬🇧 United Kingdom1.4%
🇨🇭 Switzerland0.7%
🇺🇸 United States0.7%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ViCentra on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ViCentra’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.